Is there a place for the combination of brentuximab vedotin and bendamustine in treatment of patients with relapsed/refractory Hodgkin lymphoma?

Journal article published in 2057 by Robert W. Chen

Full text: Unavailable

Publisher: AME Publishing Company

Preprint: policy unknown. Upload

Postprint: policy unknown. Upload

Published version: policy unknown. Upload

Contact authors Contact